Compare INDV & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDV | SXI |
|---|---|---|
| Founded | N/A | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 2014 | 1994 |
| Metric | INDV | SXI |
|---|---|---|
| Price | $39.39 | $257.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $289.67 |
| AVG Volume (30 Days) | ★ 1.7M | 199.1K |
| Earning Date | 06-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | 0.69 | ★ 1.42 |
| Revenue | ★ $1,239,000,000.00 | $604,535,000.00 |
| Revenue This Year | N/A | $14.87 |
| Revenue Next Year | N/A | $6.07 |
| P/E Ratio | ★ $56.60 | $176.33 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $10.91 | $144.62 |
| 52 Week High | $40.02 | $284.71 |
| Indicator | INDV | SXI |
|---|---|---|
| Relative Strength Index (RSI) | 76.84 | 46.38 |
| Support Level | $29.71 | $247.22 |
| Resistance Level | N/A | $269.09 |
| Average True Range (ATR) | 1.50 | 13.74 |
| MACD | 0.71 | -2.83 |
| Stochastic Oscillator | 92.78 | 48.62 |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.